| Name | N-acetyltransferase 1 (arylamine N-acetyltransferase) |
| Description | This gene is one of two arylamine N-acetyltransferase (NAT) genes in the human genome, and is orthologous to the mouse and rat Nat2 genes. The enzyme encoded by this gene catalyzes the transfer of an acetyl group from acetyl-CoA to various arylamine and hydrazine substrates. This enzyme helps metabolize drugs and other xenobiotics, and functions in folate catabolism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nArylamine N‐acetyltransferase 1 (NAT1) is a highly polymorphic phase II enzyme that performs dual functions in human cells. First, as a key component of the NatA complex, NAT1 catalyzes the irreversible N‑terminal acetylation of nascent proteins, modulating their stability and function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In parallel, NAT1 is central to the metabolism of exogenous aromatic amines and heterocyclic compounds found in tobacco smoke, well‐cooked meats, and various xenobiotics. Structural investigations using high‐resolution crystallography have elucidated the enzyme’s substrate specificity and highlighted the essential role of a reactive active‐site cysteine, whose integrity is crucial for catalytic activity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, studies indicate that under oxidative stress conditions, NAT1 activity is modulated by reactive oxygen and nitrogen species – for example, exposure to hydrogen peroxide or peroxynitrite rapidly inactivates the enzyme via oxidation of its catalytic cysteine, a process that can be reversed by reducing agents."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its intrinsic regulation, NAT1 plays a fundamental role in the biotransformation of potentially harmful xenobiotics. By catalyzing N‑, O‑, and N,O‑acetylation reactions, NAT1 can either detoxify aromatic amines or convert them into reactive intermediates that bind to DNA, thereby contributing to carcinogen activation. Several epidemiologic studies have linked NAT1 genetic variants – including the putative rapid‐acetylator allele NAT1*10 – to altered susceptibility to cancers of the colon, lung, bladder, pancreas, and even to developmental birth defects such as orofacial clefts when combined with environmental exposures like cigarette smoke or high‐temperature meat cooking."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nDysregulation of NAT1 in tumor tissues further underscores its biomedical importance. In several studies, increased NAT1 expression has been documented in breast carcinomas – particularly in estrogen receptor‑positive tumors – where enhanced enzyme levels correlate with accelerated cell growth, resistance to cytotoxic drugs, and increased invasive potential. These observations suggest that NAT1 not only influences carcinogen metabolism but may also directly contribute to cancer progression, making it a promising target for therapeutic intervention. Emerging evidence from cellular studies underscores that inhibition of NAT1 activity can reduce tumor cell proliferation and invasion, while genetic polymorphisms in NAT1 are being explored as potential biomarkers for cancer risk and treatment outcome."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "28"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Thomas Arnesen, Petra Van Damme, Bogdan Polevoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0901931106"}], "href": "https://doi.org/10.1073/pnas.0901931106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19420222"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19420222"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "N Brockton, J Little, L Sharp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Epidemiol (2000)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/oxfordjournals.aje.a010289"}], "href": "https://doi.org/10.1093/oxfordjournals.aje.a010289"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "10791558"}], "href": "https://pubmed.ncbi.nlm.nih.gov/10791558"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hong Wu, Ludmila Dombrovsky, Wolfram Tempel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M704138200"}], "href": "https://doi.org/10.1074/jbc.M704138200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17656365"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17656365"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "A Sekine, S Saito, A Iida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s100380170065"}], "href": "https://doi.org/10.1007/s100380170065"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11393533"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11393533"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Noureddine Atmane, Julien Dairou, Angela Paul, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Redox regulation of the human xenobiotic metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1). Reversible inactivation by hydrogen peroxide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M303813200"}], "href": "https://doi.org/10.1074/jbc.M303813200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12832400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12832400"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Julien Dairou, Noureddine Atmane, Fernando Rodrigues-Lima, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Peroxynitrite irreversibly inactivates the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 (NAT1) in human breast cancer cells: a cellular and mechanistic study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M311469200"}], "href": "https://doi.org/10.1074/jbc.M311469200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14672957"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14672957"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "L Le Marchand, J H Hankin, L R Wilkens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2001)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11751443"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11751443"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Carmen Lilla, Emaculate Verla-Tebit, Angela Risch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-05-0618"}], "href": "https://doi.org/10.1158/1055-9965.EPI-05-0618"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16434594"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16434594"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Edine W Tiemersma, Ellen Kampman, H B Bueno de Mesquita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Causes Control (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1023/a:1015236701054"}], "href": "https://doi.org/10.1023/a:1015236701054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12074508"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12074508"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "David W Hein "}, {"type": "b", "children": [{"type": "t", "text": "N-acetyltransferase SNPs: emerging concepts serve as a paradigm for understanding complexities of personalized medicine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Expert Opin Drug Metab Toxicol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1517/17425250902877698"}], "href": "https://doi.org/10.1517/17425250902877698"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19379125"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19379125"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Maja Krajinovic, Damian Labuda, Geraldine Mathonnet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11895912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11895912"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Shanbeh Zienolddiny, Daniele Campa, Helge Lind, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgn020"}], "href": "https://doi.org/10.1093/carcin/bgn020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18258609"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18258609"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Federica Gemignani, Stefano Landi, Neonilia Szeszenia-Dabrowska, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgm021"}], "href": "https://doi.org/10.1093/carcin/bgm021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17259654"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17259654"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Mariana C Stern, Laura R Johnson, Douglas A Bell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12376500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12376500"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Edward J Lammer, Gary M Shaw, David M Iovannisci, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Maternal smoking and the risk of orofacial clefts: Susceptibility with NAT1 and NAT2 polymorphisms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Epidemiology (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.ede.0000112214.33432.cc"}], "href": "https://doi.org/10.1097/01.ede.0000112214.33432.cc"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15127906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15127906"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ute Nöthlings, Jennifer F Yamamoto, Lynne R Wilkens, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Meat and heterocyclic amine intake, smoking, NAT1 and NAT2 polymorphisms, and colorectal cancer risk in the multiethnic cohort study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Epidemiol Biomarkers Prev (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1055-9965.EPI-08-1218"}], "href": "https://doi.org/10.1158/1055-9965.EPI-08-1218"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19549810"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19549810"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Donghui Li, Li Jiao, Yanan Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgi171"}], "href": "https://doi.org/10.1093/carcin/bgi171"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15987714"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15987714"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Harriet Wikman, Päivi Piirilä, Christina Rosenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "N-Acetyltransferase genotypes as modifiers of diisocyanate exposure-associated asthma risk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenetics (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00008571-200204000-00007"}], "href": "https://doi.org/10.1097/00008571-200204000-00007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11927838"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11927838"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Gail McKeown-Eyssen, Cornelia Baines, David E C Cole, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Case-control study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Epidemiol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/ije/dyh251"}], "href": "https://doi.org/10.1093/ije/dyh251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15256524"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15256524"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Shioto Suzuki, Youko Muroishi, Isao Nakanishi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastroenterol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00535-003-1281-x"}], "href": "https://doi.org/10.1007/s00535-003-1281-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15064998"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15064998"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "J Esteban Castelao, Jian-Min Yuan, Manuela Gago-Dominguez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Carotenoids/vitamin C and smoking-related bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.20104"}], "href": "https://doi.org/10.1002/ijc.20104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15095308"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15095308"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Louise Wideroff, Thomas L Vaughan, Federico M Farin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Detect Prev (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cdp.2007.03.004"}], "href": "https://doi.org/10.1016/j.cdp.2007.03.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17646057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17646057"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Olga L van der Hel, Petra H M Peeters, David W Hein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pharmacogenetics (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/00008571-200307000-00005"}], "href": "https://doi.org/10.1097/00008571-200307000-00005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12835615"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12835615"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "M Krajinovic, P Ghadirian, C Richer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1097-0215(200102)9999:9999"}, {"type": "a", "children": [{"type": "t", "text": "::aid-ijc1184"}], "href": "::aid-ijc1184"}, {"type": "t", "text": "3.0.co;2-h"}], "href": "https://doi.org/10.1002/1097-0215(200102"}, {"type": "t", "text": "9999:9999"}, {"type": "a", "children": [{"type": "t", "text": "::aid-ijc1184"}], "href": "::aid-ijc1184"}, {"type": "t", "text": "3.0.co;2-h) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11291049"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11291049"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Paul J Adam, Joanne Berry, Julie A Loader, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2003)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14517345"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14517345"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Jacky M Tiang, Neville J Butcher, Rodney F Minchin "}, {"type": "b", "children": [{"type": "t", "text": "Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.01.087"}], "href": "https://doi.org/10.1016/j.bbrc.2010.01.087"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20100460"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20100460"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Suleeporn Sangrajrang, Yasunori Sato, Hiromi Sakamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-010-0804-4"}], "href": "https://doi.org/10.1007/s10549-010-0804-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20180013"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20180013"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Larissa Wakefield, James Robinson, Hilary Long, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Arylamine N-acetyltransferase 1 expression in breast cancer cell lines: a potential marker in estrogen receptor-positive tumors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.20512"}], "href": "https://doi.org/10.1002/gcc.20512"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17973251"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17973251"}]}]}]}
|
| Synonyms | MNAT, NAT-1, AAC1, NATI |
| Proteins | ARY1_HUMAN |
| NCBI Gene ID | 9 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
NAT1 has 6,549 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 97 datasets.
Click the + buttons to view associations for NAT1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAT1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAT1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of NAT1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of NAT1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of NAT1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAT1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAT1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAT1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of NAT1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with NAT1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with NAT1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NAT1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of NAT1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of NAT1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAT1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing NAT1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with NAT1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAT1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with NAT1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with NAT1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with NAT1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of NAT1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by NAT1 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with NAT1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with NAT1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with NAT1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with NAT1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with NAT1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for NAT1 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NAT1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of NAT1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of NAT1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing NAT1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with NAT1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with NAT1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of NAT1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with NAT1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing NAT1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of NAT1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NAT1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of NAT1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAT1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of NAT1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of NAT1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving NAT1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing NAT1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by NAT1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by NAT1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of NAT1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of NAT1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAT1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of NAT1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with NAT1 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with NAT1 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of NAT1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for NAT1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of NAT1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of NAT1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of NAT1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of NAT1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of NAT1 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with NAT1 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for NAT1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with NAT1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for NAT1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of NAT1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving NAT1 protein from the KEGG Pathways dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of NAT1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of NAT1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with NAT1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of NAT1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of NAT1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of NAT1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of NAT1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing NAT1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain NAT1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting NAT1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of NAT1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by NAT1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of NAT1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| MW Enzyme Metabolite Associations | interacting metabolites for NAT1 protein from the MW Gene Metabolite Associations dataset. | |
| NURSA Protein Complexes | protein complexs containing NAT1 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for NAT1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of NAT1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of NAT1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving NAT1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving NAT1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2014 | pathways involving NAT1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving NAT1 protein from the Reactome Pathways 2024 dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of NAT1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at NAT1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of NAT1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of NAT1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of NAT1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of NAT1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with NAT1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| WikiPathways Pathways 2014 | pathways involving NAT1 protein from the Wikipathways Pathways 2014 dataset. | |